findmyKOL

Karamjeet Sandhu, MD

Basic profile

City Of Hope National Medical Center

ORCIDNPI
RegionDuarte, CA · WestSpecialtyHematologyFocusHematology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Karamjeet Sandhu is a Hematology physician affiliated with City Of Hope National Medical Center. OpenAlex indexes 241 publications with 1,884 citations (h-index 22); ClinicalTrials.gov lists 6 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
241publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,884citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials
15companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1500 Duarte Rd
Dept Of Hematology & Hematopoietic Cell Transplantation
Duarte, CA 910103012

Telephone

626-256-4673

Provider last certified this registry record 9 Nov 2020.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    39.5%
    Kinase inhibitor30.6%
    Jakafi44%Iclusig28%Sprycel28%
    Part D<11 patients
    BCL-2 Inhibitor4.7%
    Venclexta100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    20.5%
    Corticosteroid5.8%
    Prednisone100%
    Part D<11 patients
    Aluminum Complex5.4%
    Sucralfate100%
    Part D<11 patients

    + 2 more classes in this area

  • Anti-infectives

    13.6%
    Fluoroquinolone Antibacterial7.8%
    Levofloxacin100%
    Part D<11 patients
    Azole Antifungal5.8%
    Posaconazole100%
    Part D<11 patients
Where care is delivered (Part B)98.1% facility · 1.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”